ERVW-1 and infection: As shown in Fig. 1B, P52 and MT-WQ-IDL demonstrated less potent inhibition (60 to 79% and 79 to 93% depending on Env, respectively) than other peptides, which blocked HIV-1 cell-free infection at levels of 98% or higher.